InsidersTradesSigma
Discover the full management transaction log of BioPharmX Corp, a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). The latest transaction was reported on 15 January 2016 (Acquisition). Among the most active insiders: Morlock Stephen. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
BioPharmX Corp is a company focused on developing pharmaceutical products for the treatment of skin diseases. It is listed on NASDAQ under the ticker XNAS.